April 5 (Reuters) - Intercept Pharmaceuticals Inc:
* INTERCEPT PHARMACEUTICALS ANNOUNCES PRICING OF UPSIZED $250 MILLION PUBLIC OFFERING AND CONCURRENT PRIVATE PLACEMENT OF COMMON STOCK
* PRICED UPSIZED PUBLIC OFFERING OF 2.3 MILLION SHARES OF ITS COMMON STOCK AT A PRICE TO PUBLIC OF $64.00 PER SHARE Source text for Eikon: Further company coverage:
